104+ Free CCRP Practice Questions

Prepare for the Certified Clinical Research Professional exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

64% Pass Rate

104+ Questions

100% Free

Loading practice questions...

2026 Statistics

Key Facts: CCRP Exam

64%

Pass Rate (2025)

SOCRA

10,436

Active CCRPs

SOCRA 2026 program overview

130 Qs

Exam Questions

100 scored + 30 pilot

4 hours

Time Limit

SOCRA

$510

Exam Fee (members)

SOCRA North America

3 years

Certification Validity

45 CE hours to renew

The SOCRA CCRP exam has 130 multiple-choice questions (100 scored and 30 unscored beta items) with a 4-hour time limit. You must correctly answer 71 of 100 scored questions to pass. SOCRA currently lists 10,436 certified CCRPs and reports a 64% pass rate among 1,482 candidates in 2025. Beginning January 1, 2026, the exam content reflects ICH GCP E6(R3).

Sample CCRP Practice Questions

Try these sample questions to test your CCRP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 104+ question experience with AI tutoring.

1Which historical document established the principle that voluntary consent of the human subject is absolutely essential for ethical research?

A.The Declaration of Helsinki

B.The Nuremberg Code

C.The Belmont Report

D.The Common Rule

Explanation: The Nuremberg Code (1947) was the first international document to establish ethical principles for human experimentation. Its first principle states that the voluntary consent of the human subject is absolutely essential, arising directly from the Nuremberg Trials of Nazi doctors who conducted experiments on concentration camp prisoners.

2Under 21 CFR Part 56, what is the minimum number of members required for an Institutional Review Board (IRB)?

A.Three members

B.Five members

C.Seven members

D.Nine members

Explanation: According to 21 CFR 56.107, an IRB must have at least five members with varying backgrounds to promote complete and adequate review of research activities. The membership must include at least one member whose primary concerns are scientific and one whose primary concerns are nonscientific, as well as one member who is not affiliated with the institution.

3Which phase of a clinical trial is primarily designed to evaluate the safety and pharmacokinetics of a new drug in a small number of healthy volunteers?

A.Phase I

B.Phase II

C.Phase III

D.Phase IV

Explanation: Phase I clinical trials are the first-in-human studies typically conducted with 20-80 healthy volunteers. The primary objectives are to determine the drug's safety profile, pharmacokinetics (absorption, distribution, metabolism, excretion), and maximum tolerated dose. These studies help establish safe dosage ranges before proceeding to efficacy testing.

4According to ICH E6(R2)/E6(R3), what is the primary purpose of Good Clinical Practice (GCP)?

A.To reduce the cost of clinical research

B.To provide assurance that the data and reported results are credible and accurate and that the rights, safety, and well-being of trial subjects are protected

C.To speed up the drug approval process

D.To ensure pharmaceutical companies maximize their return on investment

Explanation: ICH GCP provides an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials involving human subjects. Its primary purpose is to provide assurance that data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected, consistent with the principles of the Declaration of Helsinki.

5Which section of the Code of Federal Regulations governs the protection of human subjects in FDA-regulated research (informed consent)?

A.21 CFR Part 11

B.21 CFR Part 50

C.21 CFR Part 56

D.21 CFR Part 312

Explanation: 21 CFR Part 50 establishes the requirements for informed consent and protection of human subjects in clinical investigations regulated by the FDA. It outlines the basic elements of informed consent, documentation requirements, and provisions for waiver or alteration of informed consent in certain circumstances.

6The Belmont Report identifies three fundamental ethical principles for research involving human subjects. Which of the following correctly lists all three?

A.Autonomy, nonmaleficence, fidelity

B.Respect for persons, beneficence, justice

C.Confidentiality, veracity, informed consent

D.Safety, efficacy, quality

Explanation: The Belmont Report (1979) established three fundamental ethical principles: Respect for Persons (individuals should be treated as autonomous agents, and persons with diminished autonomy are entitled to protection), Beneficence (maximize possible benefits and minimize possible harms), and Justice (fair distribution of the burdens and benefits of research).

7What is an Investigational New Drug (IND) application, and to which regulatory agency is it submitted?

A.A marketing application submitted to the European Medicines Agency (EMA)

B.An application to the FDA requesting permission to administer an investigational drug to humans

C.A post-marketing safety report filed with the World Health Organization (WHO)

D.A manufacturing quality certification submitted to the DEA

Explanation: An Investigational New Drug (IND) application is submitted to the U.S. Food and Drug Administration (FDA) under 21 CFR Part 312. It requests authorization to administer an investigational drug or biological product to humans. The IND must contain information on animal pharmacology and toxicology, manufacturing information, and clinical protocols and investigator information.

8According to 21 CFR Part 50, which of the following is NOT a required basic element of informed consent?

A.A description of the procedures to be followed and identification of any experimental procedures

B.A guarantee that the treatment will be effective

C.A description of reasonably foreseeable risks or discomforts

D.A statement that participation is voluntary and refusal will involve no penalty

Explanation: A guarantee of treatment effectiveness is NOT a required element of informed consent and would actually be misleading. The basic elements required under 21 CFR 50.25 include a description of procedures, foreseeable risks, expected benefits, alternative treatments, confidentiality measures, compensation information, contact information, and a statement of voluntary participation.

9What document serves as the agreement between the investigator and the sponsor describing the obligations and commitments of each party in a clinical trial?

A.The informed consent form

B.The case report form

C.The clinical trial agreement (CTA)

D.The investigator's brochure

Explanation: The Clinical Trial Agreement (CTA) is a legally binding contract between the sponsor and the institution/investigator that outlines the responsibilities, financial arrangements, intellectual property rights, publication terms, and confidentiality obligations of each party. It must be executed before study activities begin at the site.

10Under ICH GCP, who is ultimately responsible for the medical care of trial subjects at the investigational site?

A.The sponsor

B.The clinical research coordinator

C.The qualified investigator

D.The IRB/IEC chairperson

Explanation: According to ICH GCP, the qualified investigator is responsible for all trial-related medical decisions and for ensuring that adequate medical care is provided to subjects for any adverse events, including clinically significant laboratory values. The investigator should ensure that subjects receive appropriate medical care during and after the trial.

About the CCRP Exam

The SOCRA CCRP (Certified Clinical Research Professional) certification is an internationally recognized credential for clinical research professionals. The exam covers U.S. federal regulations, ICH GCP guidelines, and ethical principles that govern the conduct of clinical trials. As of January 2026, the exam content reflects ICH E6(R3).

Questions

130 scored questions

Time Limit

240 minutes

Passing Score

71 out of 100 scored questions

Exam Fee

$510 (SOCRA)

CCRP Exam Content Outline

40%

Research Study Start-Up

Regulatory requirements of IRB/IEC, sponsors and investigators related duties/tasks for study start-up, protocol development, informed consent, IND/IDE applications

50%

Research Study Implementation

Regulatory requirements for study conduct, adverse event reporting, data management, monitoring, protocol compliance, investigational product accountability

10%

Research Study Closure

Study close-out procedures, record retention, essential document archiving, final regulatory notifications, IP disposition

How to Pass the CCRP Exam

What You Need to Know

Passing score: 71 out of 100 scored questions
Exam length: 130 questions
Time limit: 240 minutes
Exam fee: $510

Keys to Passing

Work through all 104 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

CCRP Study Tips from Top Performers

1Focus on Research Study Implementation (50% of exam) — master adverse event reporting, monitoring procedures, and protocol compliance thoroughly

2Know the key ethical documents cold: Nuremberg Code (1947), Declaration of Helsinki (1964), Belmont Report (1979) — understand what each one established

3Memorize the major CFR parts: 21 CFR 11 (electronic records), 50 (informed consent), 56 (IRBs), 312 (INDs), 812 (IDEs), and 42 CFR 11 (ClinicalTrials.gov)

4Study ICH E6(R3) concepts including quality by design, proportionality, risk-based monitoring, and critical data/processes identification

5Understand safety reporting timelines: 7 days for fatal/life-threatening SUSARs to FDA, 15 days for other serious unexpected reactions, 24 hours investigator-to-sponsor

Frequently Asked Questions

What is the SOCRA CCRP exam pass rate?

SOCRA reports a 64% pass rate among 1,482 candidates in 2025. The exam displays 130 questions, including 100 scored and 30 unscored beta items, and allows four hours. Candidates must answer 71 of the 100 scored items correctly.

How much does the SOCRA CCRP exam cost?

The CCRP exam fee is $510 for members and $565 for non-members in North America. Outside North America, fees are $570 and $625. SOCRA lists a $390 North America retest total within the application year. Non-members who pass receive complimentary membership.

What are the eligibility requirements for the CCRP?

Most candidates qualify under Category 1: two years of full-time experience (or 3,500 hours part-time) as a clinical research professional within the past five years. Categories 2 and 3 allow one year of experience if you hold a clinical research degree or certificate. All applicants must work under GCP guidelines with IRB/IEC-approved protocols.

How does the SOCRA CCRP differ from ACRP certifications?

SOCRA offers one comprehensive CCRP credential for all clinical research roles, while ACRP offers role-specific certifications (CCRC, CCRA, CPI, ACRP-CP). SOCRA tests U.S. federal regulations plus ICH GCP, while ACRP tests only ICH GCP. CCRP renews every 3 years (45 CE hours), ACRP every 2 years (24 CE hours). SOCRA offers year-round testing; ACRP has fixed windows.

What topics does the CCRP exam cover?

The exam covers three content areas: Research Study Start-Up (40%), Research Study Implementation (50%), and Research Study Closure (10%). Key topics include ICH GCP E6(R3), FDA regulations (21 CFR Parts 11, 50, 56, 312, 812), informed consent, IRB/IEC requirements, adverse event reporting, clinical trial phases, data management, and bioethics (Nuremberg Code, Belmont Report, Declaration of Helsinki).

Is the CCRP exam available online?

Yes. SOCRA offers computer-based testing at Prometric centers and live remote proctoring through ProProctor. Paper-and-pencil delivery ended June 1, 2025. Candidates have one year from application acceptance to schedule the exam.

What changed on the CCRP exam in 2026?

Beginning January 1, 2026, the SOCRA CCRP exam content reflects ICH E6(R3), which was adopted in January 2025. Key changes include emphasis on quality by design, proportionality in risk management, fit-for-purpose technology use, and risk-based approaches to monitoring and oversight.